The Latest

Is HIV Itself a Marker for Worse COVID-19 Outcomes? Research Remains Mixed
Over a year into the COVID-19 pandemic, clinicians’ worst fears about HIV and COVID-19 don’t appear to have materialized—but there remains a lot of uncertainty.

Older Adults Living With HIV Often Have Delayed Entry Into Care
A new study shows that almost two-thirds of older adults who were diagnosed with HIV at a Connecticut clinic were already at an advanced stage of disease progression.

Recent Research Highlights Difficulty in Measuring Heart Disease Risk for People Living With HIV
Two studies out of Europe aimed to give data on which patients with HIV benefit most from lipid-lowering medications, but they both ultimately concluded that better CVD risk-assessment tools—targeted specifically for PLWH—are needed.

This Week in HIV Research: The Importance of Challenging Our Assumptions
Feb. 25, 2021: High HCV SVR among people using substances; geographic HIV care disparities among Black Americans; self-administered imiquimod vs. ASIL excision; PrEP uptake in syringe service programs.

“It’s About Our Community”: Newly Formed Science Initiative Aims to Center the Black Experience in HIV and COVID Care
Raniyah Copeland and Stephaun Wallace explain the mission and context for the Black AIDS Institute’s new Scientific Advisory Committee.

Injectable Long-Acting PrEP Is Safe, Highly Effective in Cisgender Women
The findings add to evidence that injectable PrEP could ultimately have greater real-world efficacy than daily oral PrEP in many populations, thanks to better adherence.

This Week in HIV Research: To Sleep, Perchance to Dream
Feb. 18, 2021: Insomnia rates among PLWH; trends in multimorbidity diagnosis; viral load control loss in the modern HIV treatment era; acceptability of HIV self-test dissemination methods.

This Week in HIV Research: Early Screening Matters, and Not Just for HIV
Feb. 11, 2021: Early comorbidity development among women living with HIV; type 2 heart attack frequency; assessing European-based CVD assessment tools; long-term cognitive dysfunction and HIV/hepatitis coinfection.

The Future of HIV Treatment and Prevention Is Coming, and It’s Spelled bNAb
New findings from the Antibody-Mediated Prevention (AMP) studies indicate that broadly neutralizing antibodies can work, but several will need to be used in combination.

This Week in HIV Research: What Risk Compensation?
Feb. 4, 2021: STI rates among PrEP users; how Medicaid expansion affects HIV testing and PrEP rates; utilizing mental health care providers in PrEP uptake; adapting HIV care in the COVID era.